The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer

Abstract

The recurrence interval of colorectal cancer is a prognostic factor. However, the use of adjuvant therapy did not prolong that interval.

Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: A systematic review

“…16 Similar findings have been objectified in patients with liver metastases. 17 Interestingly, the extent of prior surgery measured by the PSS-score does not seem to influence survival in patients with recurrence even though one may suspect more extensive prior surgery to complicate both the surgical procedure but also the postoperative morbidity. 11 Survival after local recurrence was better compared to diffuse intra-abdominal recurrence and isolated distant metastases.…”

Predictive factors of early relapse in UICC stage I–III colorectal cancer patients after curative resection

“…McCall et al [19] Journal of Surgical Oncology The relation between recurrence interval and adjuvant therapy is an important issue. Kaiser et al [35] reported that the recurrence interval of CRC is a prognostic factor. They claimed that the recurrence interval was inversely correlated with the initial tumor stage.…”

Management of Locally Recurrent Rectal Cancer

“…The overall recurrence rate for this disease is between 8 and 50% according to literature data (Das, Skibber et al 2006;Kaiser, Kang et al 2006). The risk for recurrence is highest in the first two years postoperatively (Juhl G 1990;McCall JL 1995;Micev M 2000;Krivokapic Z 2004).…”